enVVeno Medical Corporation NVNO
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 31.84% | 11.78% | 10.76% | -3.42% | -11.99% |
| Total Depreciation and Amortization | -22.47% | -3.54% | -7.39% | -8.52% | -8.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -47.21% | -11.61% | -8.46% | -0.91% | 6.66% |
| Change in Net Operating Assets | -275.16% | 113.98% | -236.55% | 103.61% | 216.71% |
| Cash from Operations | 14.56% | 14.55% | 7.54% | -3.14% | -2.83% |
| Capital Expenditure | 100.00% | 81.48% | 86.49% | 75.68% | 41.94% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 345.24% | 207.67% | 1,056.05% | 106.45% | 127.88% |
| Cash from Investing | 347.76% | 209.47% | 1,087.72% | 106.34% | 127.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -91.55% | -92.47% | -92.50% | -99.39% | -47.40% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -91.55% | -92.47% | -92.50% | -99.39% | -47.40% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 337.20% | -154.57% | 170.26% | -226.23% | 85.60% |